Anna Biosciences – Syntem – Immunotherapy Platform To Fight COVID-19
Anthony Rullo, PhD, Assistant Professor of Medicine at McMaster University discusses the Anna Biosciences Syntem Platform that deploys engineered propri...
3313 articles
Anthony Rullo, PhD, Assistant Professor of Medicine at McMaster University discusses the Anna Biosciences Syntem Platform that deploys engineered propri...
Brian LaMoreaux, MD, MS, Medical Director, Medical Affairs at Horizon Therapeutics plc discusses data presented at the 2021 European Alliance Of Associa...
Branko Kolvek, SVP of Operations at Pager, discusses the company’s virtual care collaboration platform while exploring the differences between telehea...
Nancy Di Dia, Executive Director, Chief Diversity & Inclusion Officer & Head, US DICE at Boehringer Ingelheim USA discusses her 15 years as a D&I office...
Sammy Elmariah, Director, Interventional Cardiology Research at Massachusetts General Hospital discusses his recent research "Transfemoral Tricuspid Val...
Newly appointed Chief Medical Officer of HD Medical, Inc., Shaun Setty, MD, discusses their flagship product, HD Steth, an FDA cleared Intelligent Steth...
Anne Quinn Young, MPH, Brand President of the MMRF discusses CureCloud, their latest platform designed to provide myeloma patents with their own genomic...
John Whelan, President, CEO and Director of Inhalon Biopharma, a start-up immunotherapy company developing an inhaled “muco-trapping” antibody platf...
Kathryn Lang, VP of Outcomes and Evidence at Guardant Health discusses the recent data shared at the 2021 American Society of Clinical Oncology (ASCO) o...
Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics at the Lombardi Comprehensive...